EHMT2 and cancer: On the other hand, UNC0638 [59] exhibited great GLP/G9a inhibition activity and induced apoptosis, suppressed migration, and tumor invasion in several cancers such as breast cancer [142], renal cancer [143], and ovarian cancer cells [144].